Literature DB >> 11724302

FHIT RNA and protein expression in oral squamous cell carcinomas.

W F van Heerden1, T J Swart, B Robson, T L Smith, S Engelbrecht, M B van Heerden, E J van Rensburg, K Huebner.   

Abstract

BACKGROUND: To investigate the possible role of FHIT, a possible tumour suppressor gene, in oral carcinogenesis, we examined 17 oral squamous cell carcinomas (OSCCs) for genetic alterations.
MATERIALS AND METHODS: Fresh tissue was obtained during surgery, snap-frozen in liquid nitrogen and stored at -70 degrees C. Nested PCR amplification to examine the integrity of FHIT mRNA was performed on the reverse transcribed complementary DNA obtained from the frozen normal and tumour tissue. Immunohistochemistry was done on formal in-fixed paraffin-embedded tissue protein from the same cases using a polyclonal antiserum against the full length Fhit.
RESULTS: Twelve out 17 (71%) OSCCs showed reduced or absent Fhit protein and half of the cases with reduced Fhit protein exhibited aberrant RT-PCR products.
CONCLUSION: Immunohistochemical detection of Fhit protein expression in OSCCs is the more sensitive method to determine the status of Fhit in these tumours, in agreement with previous studies of other tumour types.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724302

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Immunohistochemical characterization of FHIT expression in normal human tissues.

Authors:  Omar Kujan; Abdulwahab Abuderman; Ahmad Zahi Al-Shawaf
Journal:  Interv Med Appl Sci       Date:  2016-03

2.  A novel approach to simultaneously scan genes at fragile sites.

Authors:  Pascale Willem; Jacqueline Brown; Jan Schouten
Journal:  BMC Cancer       Date:  2006-08-08       Impact factor: 4.430

3.  Systemic evaluation and localization of resistin expression in normal human tissues by a newly developed monoclonal antibody.

Authors:  Qing Lin; Shari A Price; John T Skinner; Bin Hu; Chunling Fan; Kazuyo Yamaji-Kegan; Roger A Johns
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

4.  Cancer and the FRA3B/FHIT fragile locus: it's a HIT.

Authors:  K Huebner; C M Croce
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.